The COVID Impact 

Top life science experts share successful quality, compliance, and risk mitigation strategies during COVID and going forward.

You’ll walk away with a brand new “COVID playbook” consisting of insights and recommendations you can use immediately.

This was a live webinar, now you get the chance to see the recording 

We are sharing everything we learned about leading quality and compliance to meet and exceed goals during COVID-19 

We’ll discuss some of the main impacts of COVID-19 on life science companies with a focus on QMS and GxP related operations.

This was a live webinar, now you get the chance to see the recording 

You'll gain insights and recommendations on the best strategies, tools and capabilities you need to maintain compliance, to achieve growth, and to meet  goals.

Get the most interesting insights from Quality, GxP and Compliance leaders on how to lead in this time of crisis.

Because business must go on...


How to maintain QMS and GXP related operations in the short and long term to achieve growth and meet business goals.


How to build your risk mitigation plans during COVID-19 and address safety concerns


How to accelerate your digitization efforts with tools that deliver immediate impact with minimum capital investment


How to cut through the increased quality and compliance hurdles and to maximize efficiency

Lead the right way

Our panel of pharma and medical device experts will share with you insights and recommendations you can use immediately.

Watch This Webinar's Recording

Amnon Eylath
Vice President Head of Quality at Axcella Health

Responsible for executing the quality vision and leading all GXP Quality activities and operations.

Amnon has played a lead role working with regulators on a global scale with leading organizations such as Amgen, Lilly, Sanofi and successful startups such as Karyopharm.

Like everyone else, we’ve pivoted our strategies, and tactics to adjust to COVID and maintain safety.

You’re not alone. Join us to get the best prescriptive on tactics you need to pivot your quality and compliance strategies in order to continue growing during this period of disruption.

Mickey Landkof
VP Sales and Business Development at Dot Compliance

Mickey has over 13 years of Quality Management Systems expertise working with some of the most innovative technologies available for highly regulated industries.


He has worked on numerous quality and compliance initiatives with some of the largest life science organizations as well as many emerging startups.

Andre Butler
FDA/EU  Compliance Consultant and medical device specialist

With over 25 years of experience in medical devices, Andre is an expert in the areas of product development, quality and regulatory submissions of 510(k),  PMA and CE marked medical devices.


Andre has been a consultant to well over 30 companies’ including fortune 100 companies such as Medtronic and a predominance of startups.

Meet our experts panel